Aster DM Quality Care Ltd (ASTERDM)
₹681.15
Mkt cap
₹59,374 Cr
P/E ratio
164.00
P/B
8.40
Div yield
0.44%
ROE
11.30%
ROCE
11.60%
EPS (TTM)
₹4.15
Book value
₹81
52W range
519–891
Sector
Healthcare
Price history
Previous close
Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]
NSE ASTERDMBSE 540975
Health check
Cautious
ValuationExpensive
ProfitabilityAverage
GrowthLow
TechnicalsNeutral
52-week range
−23.58% from high₹681
₹519+31.22% from low₹891
Current
₹681.15
Prev close
₹679.20
Day
+0.29%
Price performance
1D
+0.14%
1W
+5.49%
1M
−7.33%
3M
−16.44%
6M
−2.77%
1Y
−5.60%
YTD
+10.95%
Financials
Revenue, profit & margin
P/E ratio
164.0×
ASTERDM is 270% above the sector median of 44.4×
ASTERDM164.0×
Sector median44.4×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 841 | 929 | 955 | 974 | 1,002 | 1,086 | 1,050 | 1,000 | 1,078 | 1,197 | 1,186 | 1,182 | 1,311 | |
| Expenses | 722 | 787 | 805 | 817 | 841 | 869 | 864 | 818 | 876 | 961 | 983 | 958 | 1,055 | |
| Operating Profit | 119 | 142 | 149 | 156 | 161 | 217 | 186 | 182 | 202 | 236 | 202 | 224 | 256 | |
| OPM % | 14% | 15% | 16% | 16% | 16% | 20% | 18% | 18% | 19% | 20% | 17% | 19% | 20% | |
| Other Income | -17 | -64 | 153 | -40 | 5,120 | 35 | 9 | 5 | 29 | 28 | -0 | 37 | -77 | |
| Interest | 25 | 30 | 25 | 30 | 29 | 31 | 31 | 32 | 31 | 31 | 31 | 30 | 31 | |
| Depreciation | 51 | 54 | 57 | 58 | 60 | 62 | 62 | 64 | 63 | 66 | 68 | 67 | 69 | |
| Profit before tax | 26 | -7 | 220 | 28 | 5,191 | 159 | 102 | 91 | 136 | 167 | 103 | 163 | 78 | |
| Tax % | 24% | 120% | 5% | 108% | 1% | 33% | 37% | 6% | 31% | 27% | 43% | 6% | 62% | |
| Net Profit | 20 | -15 | 209 | -2 | 5,152 | 106 | 64 | 86 | 94 | 121 | 59 | 154 | 29 | |
| EPS in Rs | 0.10 | -0.62 | 3.59 | -0.48 | 103.00 | 1.94 | 1.14 | 1.58 | 1.65 | 2.12 | 1.01 | 2.71 | 0.31 | |
| Raw PDF |
Earnings
Results dates & reactionsNext results
6 Nov '26
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move +0.84% · closed higher next day 20 of last 33
| Q2FY24 | Q3FY24 | Q4FY24 | Q1FY25 | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Broadcast | 15 Nov '23 | 8 Feb '24◦ | 29 May '24 | 1 Aug '24 | 24 Oct '24 | 31 Jan '25◦ | 21 May '25◦ | 30 Jul '25◦ | 6 Nov '25◦ | 30 Jan '26◦ | 30 Apr '26◦ | 5 Aug '26◦ |
| Earnings day | −1.49% | −1.03% | −3.77% | +6.09% | +10.31% | −3.27% | +3.35% | +2.05% | +0.82% | +1.07% | +6.25% | +0.28% |
| +1 day | −1.64% | +0.36% | −6.10% | +7.23% | +11.63% | −4.67% | +0.44% | +0.45% | −0.81% | −0.99% | +5.96% | +3.28% |
| +5 days | −1.24% | +6.68% | −11.20% | +14.65% | +10.60% | −3.73% | −1.88% | +0.31% | −1.33% | +3.60% | +5.53% | −2.11% |
| +15 days | +18.23% | +4.81% | −6.15% | +15.36% | +7.05% | −15.58% | +2.36% | +1.64% | −3.17% | +17.01% | +6.54% | −10.37% |
| +30 days | +19.93% | −0.83% | −10.63% | +19.78% | +20.91% | −12.63% | +17.90% | +4.23% | −12.96% | +21.26% | +11.27% | −10.34% |
| Filing | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202653.78%Promoter
Promoters53.78%13.39
FIIs12.26%1.73
DIIs21.66%5.99
Public12.17%9.24
Ownership trend
Peers
7 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | ₹8,448.00 | 57.74 | 1,21,469 | 0.24% | 610 | +34.17% | 7,044 | +20.56% | 17.45% |
| Manipal Health | ₹669.15 | 99.41 | 88,018 | 0.00% | 243 | −7.86% | 3,091 | +38.12% | 12.10% |
| Max Healthcare | ₹860.00 | 58.93 | 83,705 | 0.23% | 414 | −15.54% | 2,569 | +20.31% | 14.71% |
| Aster DM Quality | ₹681.15 | 164.50 | 59,374 | 0.44% | 29 | −46.12% | 1,311 | +21.60% | 11.57% |
| Fortis Health. | ₹768.15 | 54.36 | 57,992 | 0.13% | 273 | +3.39% | 2,545 | +17.46% | 13.45% |
| Narayana Hrudaya | ₹1,720.20 | 38.85 | 35,154 | 0.26% | 301 | +16.61% | 2,844 | +73.01% | 15.50% |
| Global Health | ₹1,270.30 | 59.66 | 34,156 | 0.04% | 157 | −0.18% | 1,304 | +26.50% | 17.37% |
| Median: 31 Co. | ₹509.20 | 44.38 | 6,363 | 0.00% | 30 | +17.80% | 403 | +22.28% | 14.62% |
Filings
Annual reports9
Concall transcripts93
TranscriptAug 2026PPTAug 2026RECAug 2026TranscriptJun 2026PPTJun 2026PPTMay 2026RECMay 2026TranscriptFeb 2026PPTFeb 2026RECFeb 2026PPTJan 2026TranscriptNov 2025PPTNov 2025PPTNov 2025TranscriptAug 2025PPTAug 2025TranscriptMay 2025PPTMay 2025TranscriptFeb 2025PPTFeb 2025TranscriptDec 2024PPTDec 2024PPTNov 2024TranscriptNov 2024
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 28 Oct - Earnings conference call scheduled for 6 November 2026 for Q2 and H1 FY27 results.Board Meeting Intimation for Approval Of Unaudited Financial Results Of The Company For The Quarter And Half Year Ended 30 Sep 2026 28 Oct - Board meets on 6 November 2026 to approve Q2 and half-year FY2026-27 results.Transcript Of The 18Th Annual General Meeting Held On 28 September 2026 Through Video Conferencing ("VC") 14 Oct - Transcript of 18th AGM on 28 Sep 2026; merger effective 1 Jul, FY26 revenue Rs9,273 crore.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Oct - Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 September 2026Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 30 Sep